Neurodegenerative Disorder Therapeutics Market is estimated to be US$ 21.3 billion by 2029 with a CAGR of 8.7% during the forecast period.

Neurodegenerative disorder therapeutics market accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7%. Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel, small molecule therapeutics for synaptopathies. This transaction builds on Alkermes' experience in central nervous system (CNS) diseases and expands Alkermes' CNS development efforts into a wide range of neurodegenerative disorders. In January 2020, AI Therapeutics- a clinical-stage biopharmaceutical company announced a common LAM-002 mechanism in cancer and neurodegenerative diseases which showed antitumor activity in the clinic and hope for ALS Analyst View: Growth in the prevalence of neurodegenerative among the global population drives the growth of neurodegenerative disorder therapeutics market. Rise in the number of geriatric population, results to the increased occurrence of neurodegenerative disorders. In 2017, as per World Population Prospects, the number of people above 60 years of age will increase from 962 million in 2017 to 2.1 billion in 2050 and it is estimated that people aged over 80 years will triple from 137 million in 2017 to 425 million in 2050. Further, according to data published by Alzheimer’s Association, around 5.8 million Americans are suffering with Alzheimer disease and this number is expected to grow to around 14 million by 2050. Thus, growing number of neurodegenerative diseases among the ageing population increases the demand for neurodegenerative disorder therapeutics thereby boosting the market growth

Silt Curtain Market is estimated to be US$ 11.43 million by 2020 with a CAGR of 3.8% during the forecast period 2030

Silt Curtain Market accounted for US$ 8.0 million in 2020 and is estimated to be US$ 11.43 million by 2030 and is anticipated to register a CAGR of 3.8%. Silt Curtain is also called as a ‘turbidity curtain’ which is used to contain silt and sediment that is stirred up during construction activities which takes place in or near water bodies. Silt Curtains are made up of porous geotextile material and deployed using solid floatation elements like conventional oil containment boom. If Silt Curtains are properly installed then it can function as floating silt fence and able to retain sediment within their boundaries which limit the sediment to get discharged into the water bodies. Silt Curtain helps to control the migration of suspended sediment and suspended silt and use to facilitate the localized settling. Thus, construction in water bodies is increasing which leads to increase in installation of Silt Curtains in water bodies to prevent sedimentation and protect aquatic animals and plants. Thus, increase in environmental awareness is expected to boost the target market growth. The report “Global Silt Curtain Market, By Type (Silt Fence, Turbidity Barriers, Sediment, Silt Barrier, Floating Turbidity, Dredging) and Others, By Application (Construction, Erosion Control) and Others, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 “ Key Highlights: In Jan, 2017, The Ecocoast produced and manufactured the screen for ‘The Ocean Cleanup’s System 001’, which was fully customized solution. The manufacture of Silt Curtain is carried out as it would be recycled and reused. Strongest Silt Curtains are manufactured by the Ecocoast in the world. Analyst View: In many countries it has been compulsory to have an installation of Silt Curtains before starting any construction and mechanical work in water. Evolving applications of Silt Curtain from dredging sites to broader segments of sedimentation will help to increase in Silt Curtain market growth. Awareness of environment is also the key factor for use of Silt Curtain in water which boosts the growth in market.

Veterinary Imaging Market

Veterinary Imaging Market accounted for US$ 1.5 billion in 2020 and is estimated to be US$ 3.00 billion by 2030 and is anticipated to register a CAGR of 7.3%. Veterinary imaging is a branch of veterinary medicine, veterinary imaging is used to obtain different medical images of animals for diagnosis of various chronic diseases. This veterinary imaging instrument is in high demand due to the increase in pet adoption and pet owners' focus on pet health. Veterinary imaging system is included various type of Imaging systems such as radiography, X-ray, MRI, CT imaging, endoscopy imaging, and ultrasound imaging ,this system is used to  diagnose diseases in livestock animals, companion animals, and large animals. Scanning is used to treat brain abnormalities, spinal herniation, brain tumors, brain and spinal cord trauma, ligament and tendon related problems in animals. Diagnostic imaging provides accurate information about structural or disease related changes. Increasing costs of pet insurance and animal health are increasing the demand for veterinary imaging. High demand for dairy and meat products, rising population of livestock, increase in awareness in pet owners regarding better treatments for pets, and increase in adoption of pets are other factors expected to drive growth of the global veterinary imaging market over the forecast period. The report " Global Veterinary Imaging Market, By Product (Instrument, Reagents, Services), By Animal (Large Animals, Small Companion Animals, Others (Exotic Animals & Birds)), By Applications (Oncology, Orthopaedics and Traumatology, Neurology, Cardiology, Other (ophthalmology & dentistry)), By End User (Clinics & Hospitals, Reference Labs, and Other and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’ Key Highlights: In August 2022, SignalPET revolutionizes in-clinic diagnostics in the UK with AI powered radiology for IVC Evidensia.-- Evidensia has adopted new technology this technology is uses artificial intelligence to provide accurate and exceedingly rapid radiology readings, slashing diagnostic time from days to minutes. The point-of-care radiology technology, developed and patented by SignalPET, sends X-rays films through an AI Machine Learning technology to get the results back instantly, much quicker than sending them to a radiology specialist to analyze results, which can take up to three days. Analyst View: Veterinary imaging is a field of veterinary medicine that involves the collection of medical images of animals to diagnose diseases, bone fractures. And this imaging identify the problem in bones as well as tissues and can help with find out nerve damage and dysfunction. Increasing pet adoption and increase in the number of veterinarians worldwide is expected to increase the demand for these systems. The veterinary imaging market is expected to grow due to increased insurance coverage for domestic as well as livestock animals, due to high cost associated with imaging systems.

Hybrid Fiber Optic Connector Market

Hybrid Fiber Optic Connector Market accounted for US$ 738.9 million in 2020 and is estimated to be US$ 1547.10 million by 2030 and is anticipated to register a CAGR of 7.8%. Hybrid Fiber Optic connector is in demand for high-performance connectors and growing in order to assure enough optical, mechanical, and environmental performance in various industries, such as military & aerospace, oil & gas, and railways, amongst others. The market is expected to witness significant growth prospects, attributes to the growing demand for spark-free, safer media for use in precarious surroundings, such as aircraft fuel cells. The report “Global Hybrid Fiber Optic Connector Market, By Type (FC, PC (Including SPC or UPC), and APC), By Application (Telecom, Oil & Gas, Military & Aerospace, Medical, and Railway), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Trends, Analysis, and Forecast till 2030 “ Key Highlights: In May 2022, CDM Electronics offers High Achievement Fiber Optic Interconnect Solutions. CDM Electronics, a chief authorized distributor of electronic connectors and cables CDM Electronics has generated interconnect product and engineered cable assembly solutions to the world's leading aerospace, military, telecom, automotive, industrial, commercial, and alternative energy providers. In May 2018, LEMO announced the launch of 3k.93.C.Y, a connector for the interconnecting of professional broadcast industry’s HD video cameras. Analyst View:

Influenza Vaccines Market

Influenza Vaccines, protect against the four influenza viruses that research indicates, an influenza A (H1N1) virus, an influenza A (H3N2) virus, and two influenza B viruses.  Influenza is contagious respiratory infection, marked with fever, cough, joint pain, muscles, headache, and severe weakness. Further, according to the World Health Organization (WHO), 2018, influenza cases related hospitalization ranges in 3-5 million cases for severe illness. Increasing clinical trials for brand new product development by key players is anticipated to power the worldwide influenza vaccines market boom over the forecast period. For instance, on May 25, 2022, Osivax, a biopharmaceutical employer growing vaccines in opposition to highly mutating infectious viruses and sicknesses, introduced an replace at the scientific improvement plan of its lead candidate, OVX836. Region Analysis: North America holds the significant share in 2018 and is predicted to hold conserving a big proportion over the forecasted period owing to the growing consumer knowledge, regarding the product benefits. Further, there are many collaborations taking place in order to increase the supply of influenza vaccines. For instance, Centers for Disease Control and Prevention (CDC), THE Food and Drug Administration (FDA), the U.S. Department of Health and Human Services Biomedical Advanced Research, and Development Authority (BARDA) and the National Institutes of Health (NIH). Key Development: In August 2022 – Emergex, a UK company plans to manufacture sufficient levels of its universal influenza vaccine for use in Phase I human trials. Emergex started that its vaccine works differently to traditional influenza vaccines, by priming influenza-specific CD8 T cells that are able to recognize the same peptides when presented n the surface of infected cells.
+ 1 interests